Press Releases

GlobeNewswire, Inc.

Financial Highlights† Reported revenue of $418.8 million, up 10% Constant currency revenue* and constant currency revenue, organic* up 9% and up 9%, respectively GAAP operating margin of 14.4%, compared to 12.3% in prior year period Non-GAAP...

GlobeNewswire, Inc.

TEL AVIV, Israel, July 31, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel...

GlobeNewswire, Inc.

Successful initiation of the Phase 2/3 clinical trial of SIL204 at Tel Aviv Sourasky Medical Center (“TASMC” or “Ichilov”), one of Israel’s largest and most prominent academic medical centers, clears the site to commence patient screening...

GlobeNewswire, Inc.

NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- This funding accelerates Assured’s mission to replace manual healthcare provider operations with AI agents, so providers get onboarded faster and patients receive care sooner.

DVIDS - Georgia

The Kentucky Air National Guard’s 123rd Medical Group has been named Air National Guard Medical Unit of the Year, and two of its officers have been recognized for individual excellence in the 2025 Air National Guard Medical Service Awards.

GlobeNewswire, Inc.

PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will...

GlobeNewswire, Inc.

ZURICH, Switzerland, July 31, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. (Nasdaq: NCEL), a clinical-stage biopharmaceutical company developing stem cell-based therapies for type 1 diabetes, today announced that it has entered into securities purchase...

GlobeNewswire, Inc.

NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. (“Agios” or the “Company”) (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at...

GlobeNewswire, Inc.

NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or...

GlobeNewswire, Inc.

NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ionis Pharmaceuticals, Inc. (“Ionis” or the “Company”) (NASDAQ: IONS). Such investors are advised to contact Danielle Peyton at...

GlobeNewswire, Inc.

NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such investors are advised to contact Danielle...

GlobeNewswire, Inc.

NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC). Such investors are advised to contact Danielle Peyton at...

EIN Presswire

A Major Step in the Hospital’s AI Transformation, Collaboration Will Provide Clinicians with OpenAI's Most Advanced Clinical Reasoning Platform RAMAT GAN, ISRAEL, July 28, 2026 /⁨EINPresswire.com⁩/ -- Sheba Medical Center announced today a...

GlobeNewswire, Inc.

TEL AVIV, Israel, July 28, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus", “Nasus Pharma” or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced...

GlobeNewswire, Inc.

Ness Ziona, Israel, July 31, 2026 (GLOBE NEWSWIRE) -- QTREX Proprietary Quantum Interconnect Platform Exceeds Performance Requirements Established by Strategic Partners Ness Ziona, Israel, July 31, 2026 – QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX"...

GlobeNewswire, Inc.

Vancouver, Canada, July 28, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (“Clearmind” or “Company”) (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogen-derived treatments for Alcohol Use Disorder...

GlobeNewswire, Inc.

NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Dandy, the fully digital dental lab, today announced a partnership with Yeshiva University's new College of Dental Medicine, the first new dental school to open in New York City in over 100 years.

GlobeNewswire, Inc.

Dr. Oliver Sartor brings more than 35 years advancing the clinical development and commercialization of oncology and radiopharmaceuticals Professor Michael Hofman brings more than 20 years pioneering molecular imaging and precision...

GlobeNewswire, Inc.

MIAMI, July 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today reports business...

GlobeNewswire, Inc.

NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) that a securities class action has been filed on behalf of shareholders who purchased Regeneron securities...